What is Amneal Pharmaceuticals, Inc. Class A Common Stock's Enterprise Value?

Amneal Pharmaceuticals, Inc. Class A Common Stock's Enterprise Value is $7.9B, based on as-reported figures from SEC (XBRL) filings.

What is Amneal Pharmaceuticals, Inc. Class A Common Stock's Trailing P/E?

Amneal Pharmaceuticals, Inc. Class A Common Stock's Trailing P/E is 34.9×, based on as-reported figures from SEC (XBRL) filings.

What is Amneal Pharmaceuticals, Inc. Class A Common Stock's Price / Sales?

Amneal Pharmaceuticals, Inc. Class A Common Stock's Price / Sales is 1.8×, based on as-reported figures from SEC (XBRL) filings.

What is Amneal Pharmaceuticals, Inc. Class A Common Stock's Revenue (TTM)?

Amneal Pharmaceuticals, Inc. Class A Common Stock's Revenue (TTM) is $3.1B, based on as-reported figures from SEC (XBRL) filings.

What is Amneal Pharmaceuticals, Inc. Class A Common Stock's Net Income (TTM)?

Amneal Pharmaceuticals, Inc. Class A Common Stock's Net Income (TTM) is $157.4M, based on as-reported figures from SEC (XBRL) filings.

What is Amneal Pharmaceuticals, Inc. Class A Common Stock's Diluted EPS (TTM)?

Amneal Pharmaceuticals, Inc. Class A Common Stock's Diluted EPS (TTM) is 0.49, based on as-reported figures from SEC (XBRL) filings.

Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Financial Statements

Amneal Pharmaceuticals, Inc. Class A Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00462PGH9

XNAS · usd

17.20▲ 0.15 (0.89%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close17.05

Day's Range16.98 – 17.40

52-Week Range9.49 – 19.26

Volume2.0M

Avg Volume1.8M

Share Statistics

Shares Outstanding

Employees8,500

ExchangeXNAS

Listed2018-05-07

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)

What is Amneal Pharmaceuticals, Inc. Class A Common Stock's Market Cap?: Amneal Pharmaceuticals, Inc. Class A Common Stock's Market Cap is $5.5B, based on as-reported figures from SEC (XBRL) filings.
What is Amneal Pharmaceuticals, Inc. Class A Common Stock's Enterprise Value?: Amneal Pharmaceuticals, Inc. Class A Common Stock's Enterprise Value is $7.9B, based on as-reported figures from SEC (XBRL) filings.
What is Amneal Pharmaceuticals, Inc. Class A Common Stock's Trailing P/E?: Amneal Pharmaceuticals, Inc. Class A Common Stock's Trailing P/E is 34.9×, based on as-reported figures from SEC (XBRL) filings.
What is Amneal Pharmaceuticals, Inc. Class A Common Stock's Price / Sales?: Amneal Pharmaceuticals, Inc. Class A Common Stock's Price / Sales is 1.8×, based on as-reported figures from SEC (XBRL) filings.
What is Amneal Pharmaceuticals, Inc. Class A Common Stock's EV / Revenue?: Amneal Pharmaceuticals, Inc. Class A Common Stock's EV / Revenue is 2.5×, based on as-reported figures from SEC (XBRL) filings.
What is Amneal Pharmaceuticals, Inc. Class A Common Stock's EV / EBITDA?: Amneal Pharmaceuticals, Inc. Class A Common Stock's EV / EBITDA is 12.1×, based on as-reported figures from SEC (XBRL) filings.
What is Amneal Pharmaceuticals, Inc. Class A Common Stock's Revenue (TTM)?: Amneal Pharmaceuticals, Inc. Class A Common Stock's Revenue (TTM) is $3.1B, based on as-reported figures from SEC (XBRL) filings.
What is Amneal Pharmaceuticals, Inc. Class A Common Stock's Net Income (TTM)?: Amneal Pharmaceuticals, Inc. Class A Common Stock's Net Income (TTM) is $157.4M, based on as-reported figures from SEC (XBRL) filings.
What is Amneal Pharmaceuticals, Inc. Class A Common Stock's EBITDA?: Amneal Pharmaceuticals, Inc. Class A Common Stock's EBITDA is $651.4M, based on as-reported figures from SEC (XBRL) filings.
What is Amneal Pharmaceuticals, Inc. Class A Common Stock's Diluted EPS (TTM)?: Amneal Pharmaceuticals, Inc. Class A Common Stock's Diluted EPS (TTM) is 0.49, based on as-reported figures from SEC (XBRL) filings.